申请人:Dininno Frank
公开号:US20100279983A1
公开(公告)日:2010-11-04
This invention provides novel β-lactamase inhibitors of the aryl- and heteroarylsulfonamidomethylphosphonate monoester class having nitrogen-based cations or quarternary ammonium groups. The compounds inhibit three classes of β-lactamases and synergize the antibacterial effects of β-lactam antibiotics (e.g., imipenem and ceftazidime) against those micro-organisms normally resistant to the β-lactam antibiotics as a result of the presence of the β-lactamases. Formula (I) or pharmaceutically acceptable salt thereof.
这项发明提供了一种新型的
β-内酰胺酶抑制剂,属于芳基和杂芳基磺
酰胺基
甲基膦酸单
酯类,具有基于
氮的阳离子或季
铵基团。这些化合物抑制三类β-内
酰胺酶,并增强β-内
酰胺类
抗生素(如
亚胺培南和
头孢他啶)对那些通常对β-内
酰胺类
抗生素具有抗药性的微
生物的抗菌效果,这是由于β-内
酰胺酶的存在。公式(I)或其药学上可接受的盐。